GFAP and Parkinson disease: The literature reveals that TRX exhibits a mitigating effect in Parkinson’s 6-OHDA rat model not only via antioxidation activity but also through inhibition of astroglial GFAP expression partially by modulating the function of PI3K/ERβsignalling pathway [56].